Trident Pharmaceuticals tridentpharma.com


Public lists: Pharma Startups (4729)

Trident Pharmaceuticals is developing next-generation, orally active biopharmaceutical products that modulate autoreactive T cells to selectively downregulate the inflammation associated with autoimmune disorders and allergic diseases.

Trident Pharmaceuticals is developing next-generation, orally active biopharmaceutical products that modulate autoreactive T cells to selectively downregulate the inflammation associated with autoimmune disorders and allergic diseases.

Company (Alive / Active)

Phone: 857-366-8459

Fax:

184 High Street

Boston, 02110
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Trident Pharmaceuticals $0.3M May 21, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Trident Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Agent for treating allergic or hypersensitivity condition Jan 18, 2013 Mar 31, 2015 Patent
Agent for treating allergic or hypersensitivity condition Mar 27, 2007 Jan 22, 2013 Patent
Vaccine May 10, 1999 Mar 29, 2011 Patent
Methods for the prevention against or treatment of diabetes with etxb and/or insulin Sep 30, 2005 Sep 15, 2009 Patent
Agent for treating allergic or hypersensitivity condition Feb 23, 2015 Application
See all 6 patents